KULR Technology Group, Inc. current report, 16 September 2019

Business Context and Reporting Period

This Form 8-K Current Report was filed by KULR Technology Group, Inc. on September 19, 2019, covering events occurring on September 16, 2019, and September 19, 2019. The Company is an emerging growth company incorporated in Delaware.

Key Financial Metrics

The filing discloses specific capital raising activity but does not provide comprehensive financial statements, revenue, profit, or cash flow data for a reporting period.

  • Capital Raised: $60,000 in aggregate gross proceeds.
  • Securities Issued: 6.68 shares of Series C Preferred Stock (aggregate stated value $66,800) and warrants to purchase 16,700 shares of common stock.
  • Warrant Terms: Exercise price of $1.50 per share; expiration two years from issuance.
  • Debt and Liquidity: The filing text does not provide a clear value for total debt, cash balances, or liquidity metrics.

Material Changes

The filing reports two material events:

  1. Unregistered Sales of Equity Securities (Item 3.02): On September 16, 2019, the Company sold Series C Preferred Stock and warrants to certain investors. The sale was made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
  2. Regulation FD Disclosure (Item 7.01): On September 19, 2019, the Company announced it has conducted testing and provided battery safety solutions for a global Tier-1 manufacturer of medical equipment and devices.

Guidance, Outlook, and Risks

The filing does not contain forward-looking guidance, financial outlook, or specific risk factors beyond standard legal disclaimers regarding the unregistered sale of securities. The press release referenced in Item 7.01 indicates business development progress in the medical equipment sector but does not quantify future revenue or provide management commentary on financial performance.

Investor Verification Checklist

  • Verify the identity of the "certain investors" who purchased the Series C Preferred Stock and warrants.
  • Confirm the commercial status and potential revenue impact of the battery safety solutions provided to the global Tier-1 medical equipment manufacturer.
  • Review the attached Exhibit 99.1 (Press Release) for additional details on the medical equipment partnership.
  • Check subsequent filings for updated liquidity positions, as this 8-K does not disclose current cash balances.